The Stark Numbers
According to the latest 'Research and Development Statistics 2025-26' report from the Department of Science and Technology (DST), the role of multinationals in India's innovation landscape has surged dramatically. Their share of business R&D expenditure
jumped to 71.3% in 2023-24 from 49.9% just three years earlier in 2020-21. This data point confirms that while overall private sector R&D is growing, it is becoming increasingly concentrated within a small number of large, foreign-owned firms. Overall, India's Gross Expenditure on R&D (GERD) hit a record ₹2.45 lakh crore, or 0.84% of GDP in 2023-24, a notable rise but still below the government's target of 2%.
Why MNCs Are Doubling Down on India
For global giants, India presents a compelling proposition for R&D. The primary drivers are the availability of a large, skilled talent pool at a competitive cost, relatively low operational expenses, and the immense opportunity to develop products for the Indian market and other similar emerging economies. Many global firms now have some of their largest research centres based in the country. This influx of investment creates high-value jobs and integrates India into global supply chains for technology and innovation. Sectors like transport, pharmaceuticals, biotechnology, and IT have emerged as the biggest magnets for this R&D spending.
The Flip Side for Domestic Innovation
However, this heavy concentration is a double-edged sword. A key concern is that it could stifle the growth of indigenous R&D. Indian companies, particularly small and medium enterprises, struggle to compete for the same talent and resources. The private sector's overall contribution to national R&D has historically been low in India compared to other major economies like China and the US, where businesses drive the majority of innovation spending. There's a persistent risk-aversion among many domestic firms, which often prefer importing proven technologies over making long-term, high-risk investments in developing their own. This creates a dependency cycle and can limit India's ability to achieve true technological self-reliance, or 'Atmanirbharta'.
Does the Benefit Stay in India?
Another critical question is where the value created by this R&D ultimately flows. While MNC research centres in India contribute to product development, a significant portion of the core intellectual property (IP) and patents are often held by the parent company abroad. This means the primary economic benefits and strategic advantages may not fully accrue within India. While these centres are crucial for job creation, there is a risk of them acting as sophisticated execution hubs rather than epicentres of foundational, home-grown innovation that seeds a new generation of Indian-owned global technology leaders.
Policy Push to Rebalance the Scales
The government is acutely aware of this imbalance and has launched ambitious initiatives to catalyse domestic R&D. The establishment of the Anusandhan National Research Foundation (ANRF) and a ₹1 lakh crore Research, Development, and Innovation (RDI) fund are central to this strategy. These programmes are designed to provide long-term, low-interest financing to encourage private Indian firms to undertake high-risk, high-reward research projects. The goal is to de-risk innovation for domestic players and strengthen the weak linkages between academia and industry, a long-standing challenge in India's R&D ecosystem.
